Highlights DarioHealth Corp.

Equities

DRIO

US23725P2092

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
1.09 ^USD	-0.91%		-0.46%	-36.63%

06-05	DarioHealth Appoints Steven Nelson as Chief Commercial Officer	MT
06-05	DarioHealth Corp. Announces Management Changes	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Earnings Flash (DRIO) DARIOHEALTH Reports Q1 Revenue $5.8M, vs. Street Est of $6.8M	05-15	MT
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	04-25	CI
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	04-18	CI
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	04-10	CI
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	04-02	CI
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
North American Morning Briefing : Stocks Set for -2-	03-28	DJ
North American Morning Briefing : Investors -2-	03-21	DJ
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	03-12	CI
DarioHealth Corp. acquired Twill, Inc. for $34.4 million.	02-20	CI
DarioHealth to Provide Diabetes, Weight-Control Services for Food Services Union Members	01-11	MT
Regional Union Selects DarioHealth Corp.'s Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support	01-11	CI
National Employer Selects Dariohealth Corp. Cardiometabolic and GLP-1 Solutions to Improve Employee Health	12-05	CI
DarioHealth Corp. Contracts with New Employer for Cardiometabolic Solution	11-27	CI
Earnings Flash (DRIO) DARIOHEALTH Posts Q3 Revenue $3.5M, vs. Street Est of $5.4M	11-02	MT
DarioHealth Corp. Provides Revenue Guidance for the Year 2024	11-02	CI
DarioHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
DarioHealth Launches New Blood Sugar Meter for Apple iPhone 15 Users	11-01	MT
DarioHealth Corp. Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm	05/10/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DarioHealth Corp.

Equities

DRIO

US23725P2092

Highlights

Filters